Nutritional status in oncological patients may differ according to several modifiable and non-
modifiable factors. Knowledge of the epidemiology of malnutrition/cachexia/sarcopenia may …

Grip strength has been proposed as a biomarker. Supporting this proposition, evidence is
provided herein that shows grip strength is largely consistent as an explanator of concurrent …

Clinical and research interest in sarcopenia has burgeoned internationally, Asia included.
The Asian Working Group for Sarcopenia (AWGS) 2014 consensus defined sarcopenia as …

Sarcopenia is a progressive and generalized loss of skeletal muscle mass and function. The
prevalence of sarcopenia was reported to be up to 29% in older persons in the community …

Frailty, a consequence of the interaction of the aging process and certain chronic diseases,
compromises functional outcomes in the elderly and substantially increases their risk for …

Abstract Background in 2010, the European Working Group on Sarcopenia in Older People
(EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying …

The prevalence of obesity in combination with sarcopenia (the age-related loss of muscle
mass and strength or physical function) is increasing in adults aged 65 years and older. A …

Sarcopenia is a progressive and generalised skeletal muscle disorder involving the
accelerated loss of muscle mass and function that is associated with increased adverse …

Objective The objective is to formulate clinical practice guidelines for the treatment of
diabetes in older adults. Conclusions Diabetes, particularly type 2, is becoming more …

It is well recognized that poor muscle function and poor physical performance are strong
predictors of clinically relevant adverse events in older people. Given the large number of …